Weekly Recap | CRISPR Therap -7.3%, most brokers rate it buyWeekly Review·Sep 12 at 07:59 AMCRSP-1.52%
Weekly Recap | CRISPR Therap -3.34%, most brokers rate it buyWeekly Review·Sep 5 at 06:31 AMCRSP-1.52%
Weekly Recap | CRISPR Therap -2.99%, consensus target well above spotWeekly Review·Aug 29 at 05:32 AMCRSP-1.52%
